Drugs / Tinadizole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06065267 Comparator | Jan 2024 → Dec 2026 expected | Helicobacter pylori infectious disease | Damascus Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT04626193 Background | Oct 2020 → Dec 2023 | Helicobacter pylori infectious disease | Damascus Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tinadizole | “Levofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid” NCT06065267 ↗1“Doxycylcine 100 mg bid ,esomprazole 20 bid,levofloxacineq.d,Tinadizole 500 bid” NCT04626193 ↗ |